Literature DB >> 18048861

Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians.

Melina Gattellari, John Worthington, Nicholas Zwar, Sandy Middleton.   

Abstract

BACKGROUND AND
PURPOSE: Anticoagulation reduces the risk of stroke in nonvalvular atrial fibrillation yet remains underused. We explored barriers to the use of anticoagulants among Australian family physicians.
METHODS: The authors conducted a representative, national survey.
RESULTS: Of the 596 (64.4%) eligible family physicians who participated, 15.8% reported having a patient with nonvalvular atrial fibrillation experience an intracranial hemorrhage with anticoagulation and 45.8% had a patient with known nonvalvular atrial fibrillation experience a stroke without anticoagulation. When presented with a patient at "very high risk" of stroke, only 45.6% of family physicians selected warfarin in the presence of a minor falls risk and 17.1% would anticoagulate if the patient had a treated peptic ulcer. Family physicians with less decisional conflict and longer-standing practices were more likely to endorse anticoagulation.
CONCLUSIONS: Strategies to optimize the management of nonvalvular atrial fibrillation should address psychological barriers to using anticoagulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18048861     DOI: 10.1161/STROKEAHA.107.495036

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  33 in total

1.  Contemporary approaches to managing atrial fibrillation: A survey of Australian general practitioners.

Authors:  Beata Bajorek; Parker Magin; Sarah Hilmer; Ines Krass
Journal:  Australas Med J       Date:  2015-11-30

2.  Five years of keeping a watch on the left atrial appendage-how has the WATCHMAN fared?

Authors:  Mohammad-Ali Jazayeri; Venkat Vuddanda; Valay Parikh; Madhav Lavu; Donita Atkins; Y Madhu Reddy; Jayant Nath; Dhanunjaya R Lakkireddy
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 3.  Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future.

Authors:  Ramsey M Wehbe; Ajay Yadlapati
Journal:  Tex Heart Inst J       Date:  2016-08-01

4. 

Authors:  Nicholas R Jones; F D Richard Hobbs; Clare J Taylor
Journal:  Can Fam Physician       Date:  2017-12       Impact factor: 3.275

5.  Underuse of anticoagulation therapy for atrial fibrillation: Are we failing our patients?

Authors:  Nicholas R Jones; F D Richard Hobbs; Clare J Taylor
Journal:  Can Fam Physician       Date:  2017-12       Impact factor: 3.275

Review 6.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

7.  Which Factors Influence Resident Physicians to Prescribe NOACs to Patients with Non-Valvular Atrial Fibrillation?

Authors:  Zardasht Oqab; William F McIntyre; Wilma M Hopman; Adrian Baranchuk
Journal:  J Atr Fibrillation       Date:  2016-08-31

Review 8.  A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks.

Authors:  Beata Bajorek
Journal:  Ther Adv Drug Saf       Date:  2011-04

9.  Stroke associated with atrial fibrillation--incidence and early outcomes in the north Dublin population stroke study.

Authors:  Niamh Hannon; Orla Sheehan; Lisa Kelly; Michael Marnane; Aine Merwick; Alan Moore; Lorraine Kyne; Joseph Duggan; Joan Moroney; Patricia M E McCormack; Leslie Daly; Nicola Fitz-Simon; Dawn Harris; Gillian Horgan; Emma B Williams; Karen L Furie; Peter J Kelly
Journal:  Cerebrovasc Dis       Date:  2009-11-05       Impact factor: 2.762

Review 10.  Anticoagulation in Heart Failure: a Review.

Authors:  Emily P Zeitler; Zubin J Eapen
Journal:  J Atr Fibrillation       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.